BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 4

GRADE: PCV15 use in children aged 2–18 years with certain underlying medical conditions that increase the risk of pneumococcal disease

MMWR recomm. rep; 71 (37), 2022
On June 22, 2022, ACIP recommended use of 15-valent pneumococcal conjugate vaccine (PCV15 [Vaxneuvance, Merck Sharp & Dohme LLC]) as an option for pneumococcal conjugate vaccination for persons aged <19 years according to currently recommended PCV13 dosing and schedules. A systematic review and Grading o...
Vacinas Pneumocócicas/uso terapêutico, Infecções Pneumocócicas/prevenção & controle, Fatores de Risco
Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Pneumococcal Vaccines for Adults aged ≥65 years

MMWR recomm. rep; 63 (37), 2014
GRADE was used to evaluate 13-valent Pneumococcal Conjugate Vaccine (PCV13) for routine use among adults aged ≥65 years. Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods.[1] The primary policy question was “Should PCV13 be adm...
Vacinas Pneumocócicas/uso terapêutico, Infecções Pneumocócicas/imunologia, Vacinas Pneumocócicas/efeitos adversos, Imunogenicidade da Vacina
Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) of Pneumococcal Vaccines for Immunocompromised Children Aged 6 through 18 Years

MMWR recomm. rep; 62 (25), 2013
GRADE was used to evaluate 13-valent Pneumococcal Conjugate Vaccine (PCV13) for routine use among immunocompromised children aged 6 through 18 years. Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods.[1] The primary policy question...
Vacinas Pneumocócicas/uso terapêutico, Hospedeiro Imunocomprometido, Infecções Pneumocócicas/imunologia, Anemia Falciforme/imunologia, Infecções por HIV/imunologia, Imunogenicidade da Vacina
Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Pneumococcal Vaccines for Immunocompromised Adults

MMWR recomm. rep; 61 (40), 2012
GRADE was used to evaluate 13-valent Pneumococcal Conjugate Vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) for routine use among immunocompromised adults. Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods...
Vacinas Pneumocócicas/uso terapêutico, Infecções Pneumocócicas/imunologia, Hospedeiro Imunocomprometido, Imunogenicidade da Vacina
Texto completo